TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/25/24 18:04 | 6/24/24 | ITCI | Intra-Cellular Therapies, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Riggs Rory B | NY | D | S.d | -337 | 75.57 | 0 | -4 | -4 | 117 | D | |||||||||||||||
1/4/24 17:16 | 1/2/24 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Riggs Rory B | NY | D | S.m | -13,223 | 28.13 | 0 | -470 | -80 | 120 | D | |||||||||||||||
5/22/23 20:36 | 5/22/23 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Riggs Rory B | NY | D | S | -57,435 | 32.82 | 0 | -1,750 | -94 | 107 | D | |||||||||||||||
3/30/23 17:53 | 3/29/23 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Riggs Rory B | NY | D | S.m | -5,081 | 36.31 | 0 | -140 | -8 | 1,557 | D | |||||||||||||||
12/13/22 18:20 | 12/9/22 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Riggs Rory B | NY | D | S.m | -2,521 | 42.01 | 0 | -60 | -23 | 197 | D | |||||||||||||||
11/21/22 18:12 | 11/17/22 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Riggs Rory B | NY | D | S | -5,080 | 42.33 | 0 | -120 | -32 | 257 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |